Intravitreal Bevacizumab May Increase Diabetic Macular Edema in Eyes with Attached Posterior Vitreous

Publisher： Karger

E-ISSN： 1663-2699|4|1|7-10

ISSN： 1663-2699

Source： Case Reports in Ophthalmology, Vol.4, Iss.1, 2013-01, pp. : 7-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of Intravitreal Bevacizumab versus Triamcinolone for the Treatment of Diffuse Diabetic Macular Edema

By  

Ophthalmologica, Vol. 224, Iss. 4, 2010-02 ,pp. : 258-264

Karger

Access to resources Recommend Favorite

Comparison of the Effectiveness of Intravitreal Ranibizumab for Diabetic Macular Edema in Vitrectomized and Nonvitrectomized Eyes

By  

Ophthalmologica, Vol. 236, Iss. 2, 2016-07 ,pp. : 67-73

Karger

Access to resources Recommend Favorite

Comparison of Intravitreal Triamcinolone Acetonide with Intravitreal Bevacizumab for Treatment of Diabetic Macular Edema: A Meta-analysis

By Zhang Yue   Ma Jinlan   Meng Nana   Li Hao   Qu Yi  

Current Eye Research, Vol. 38, Iss. 5, 2013-05 ,pp. : 578-587

Informa Healthcare

Access to resources Recommend Favorite

Comparison of Grid Laser, Intravitreal Triamcinolone, and Intravitreal Bevacizumab in the Treatment of Diffuse Diabetic Macular Edema

By  

Ophthalmologica, Vol. 227, Iss. 2, 2011-09 ,pp. : 95-99

Karger

Access to resources Recommend Favorite

The Effectiveness of Intravitreal Ranibizumab in Patients with Diabetic Macular Edema Who Have Failed to Respond to Intravitreal Bevacizumab

By  

Ophthalmologica, Vol. 235, Iss. 3, 2016-03 ,pp. : 133-136

Karger

Access to resources Recommend Favorite